Dr Lise Lafferty

Senior Lecturer

PhD, The Kirby Institute, UNSW Sydney (2017)
Master of Indigenous Studies, UNSW Sydney (2011)
Master of (International) Social Development, UNSW Sydney (2011)

��

Medicine & Health

The Kirby Institute

Dr Lise Lafferty is a Senior Research Fellow with a co-appointment across the Centre for Social Research in Health and the Surveillance Evaluation and Research Program, The Kirby Institute. Her research��interests include people who inject drugs (including those in prison and in the community), blood-borne viruses (particularly hepatitis C),��sexual health, and Aboriginal health. She has a community background working with diverse disadvantaged communities including people with disabilities, young people at risk of entering the criminal justice system, and Aboriginal communities. ��

��

E-mail

l.lafferty@unsw.edu.au

Journal articles | 2024

Chandra S; Broom A; Ridge D; Peterie M; Lafferty L; Broom J; Kenny K; Treloar C; Applegate T, 2024, 'Treatment ‘cultures’, sexually transmitted infections and the rise of antimicrobial resistance', Sociology of Health and Illness,

Journal articles | 2024

Kronfli N; Lafferty L; Leone F; Stoové M; Hajarizadeh B; Lloyd AR; Altice FL, 2024, 'Using nominal group technique to identify perceived barriers and facilitators to improving uptake of the Prison Needle Exchange Program in Canadian federal prisons by correctional officers and healthcare workers', International Journal of Drug Policy, 130,

Journal articles | 2024

Lafferty L; Altice FL; Leone F; Stoové M; Lloyd AR; Hajarizadeh B; Kronfli N, 2024, 'Using nominal group technique with people who are incarcerated in Canadian federal prisons to identify barriers and solutions to improving Prison Needle Exchange Program uptake', International Journal of Drug Policy, 131,

Journal articles | 2024

Lafferty L; Beadman M; Ward J; Flynn E; Hosseini-Hooshyar S; Martinello M; Treloar C, 2024, 'Patient and healthcare provider perceptions of acceptability of fingerstick point-of-care hepatitis C testing at Aboriginal Community Controlled Health Services in Australia', International Journal of Drug Policy, 125,

Journal articles | 2024

Lafferty L; Rautenbach C; McNulty A; Ryder N; Slattery C; Houghton R; Kenigsberg A; Murray C; Carrington N; Patel P, 2024, 'Client and staff perceptions of acceptability of MyCheck: a direct-to-pathology telehealth and e-testing service for comprehensive bloodborne virus and sexually transmissible infection screening', Sexual Health, 21, pp. SH23194,

Journal articles | 2024

McCormack H; Dickson M; Harrington T; Garay M; Whybrow R; Mooney-Somers J; Aggleton P; Lafferty L; Mitchell E; Morris J; Haire B, 2024, 'Sexual healthcare to meet the needs of sexuality and gender diverse aboriginal young people: imagined possibilities', Culture, Health and Sexuality, ahead-of-print, pp. 1 - 16,

Journal articles | 2024

Sheehan Y; Cochrane A; Treloar C; Grebely J; Tedla N; Lloyd AR; Lafferty L, 2024, 'Understanding hepatitis C virus (HCV) health literacy and educational needs among people in prison to enhance HCV care in prisons', International Journal of Drug Policy, 130,

Journal articles | 2024

Sheehan Y; Lafferty L; Tedla N; Byrne M; Dawson O; Stewart S; Leber B; Habraken N; Lloyd AR, 2024, 'Development of an evidence-based hepatitis C education program to enhance public health literacy in the Australian prison sector: The Hepatitis in Prisons Education program (HepPEd)', International Journal of Drug Policy, 129,

Journal articles | 2024

Stowe MJ; Hansford L; Halford R; Wallace J; Lafferty L, 2024, 'Co-creating and implementing a novel pre-conference event to promote equity and inclusivity among academic researchers and people who use drugs', Drug and Alcohol Review,

Journal articles | 2024

Treloar C; Lancaster K; Rhodes T; Lafferty L; Bryant J; Rance J, 2024, 'The ‘missing’ in the ‘endgame’ of hepatitis C elimination: A qualitative study in New South Wales, Australia', Drug and Alcohol Review, 43, pp. 1256 - 1263,

Journal articles | 2024

Whitford K; Whybrow B; Haire B; Nikitas A; Williams S; Monaghan R; Lafferty L, 2024, 'Sexual and Reproductive Health Service Access among Aboriginal and Torres Strait Islander Young People in Regional NSW, Australia', Health & Social Care in the Community, 2024,

Journal articles | 2023

Broom A; Peterie M; Kenny K; Broom J; Kelly-Hanku A; Lafferty L; Treloar C; Applegate T, 2023, 'Vulnerability and antimicrobial resistance', Critical Public Health, 33, pp. 308 - 317,

Journal articles | 2023

Broom A; Peterie M; Ridge D; Lafferty L; Kenny K; Broom J; Kelly-Hanku A; Treloar C; Applegate T, 2023, 'Sex, drugs and superbugs: The rise of drug resistant STIs', SSM - Qualitative Research in Health, 4,

Journal articles | 2023

Grebely J; Markus C; Causer LM; Silk D; Comben S; Lloyd AR; Martinez M; Cunningham EB; O'Flynn M; Dore GJ; Matthews S, 2023, 'A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia', The Lancet Gastroenterology and Hepatology, 8, pp. 204 - 207,

Journal articles | 2023

Lafferty L; Schroeder S; Marshall AD; Drysdale K; Higgs P; Stoové M; Baldry E; Dietze P; Treloar C, 2023, 'Trust and service engagement among people who inject drugs after release from prison', International Journal of Drug Policy, 111,

Journal articles | 2023

Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd AR; Treloar C, 2023, 'Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework', Addiction, 118, pp. 1153 - 1160,

Journal articles | 2023

Marshall AD; Schroeder SE; Lafferty L; Drysdale K; Baldry E; Stoové M; Dietze P; Higgs P; Treloar C, 2023, 'Perceived access to opioid agonist treatment in prison among people with a history of injection drug use: A qualitative study', Journal of Substance Use and Addiction Treatment, 150,

Journal articles | 2023

Peterie M; Broom A; Kenny K; Broom J; Regan D; Lafferty L; Kelly-Hanku A; Treloar C, 2023, 'Economies of resistance', Critical Public Health, 33, pp. 763 - 775,

Journal articles | 2023

Sheehan Y; Cunningham EB; Cochrane A; Byrne M; Brown T; McGrath C; Lafferty L; Tedla N; Dore GJ; Lloyd AR; Grebely J, 2023, 'A ‘one-stop-shop’ point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study', Journal of Hepatology, 79, pp. 635 - 644,

Journal articles | 2023

Storer D; Lafferty L; Graham S; Murphy D; Rance J; Brener L; Seale H; Hammoud MA; Prestage G; Beadman M; Gardner K; Blaxland M; Bolt R; Caruana T; Philpot S; Rule J; Bryant J, 2023, 'Perceptions of COVID-19 Vaccines: Lessons from Selected Populations Who Experience Discrimination in the Australian Healthcare System', Health and Social Care in the Community, 2023, pp. 1 - 10,

Journal articles | 2023

Treloar C; Rance J; Bryant J; Lafferty L, 2023, ''There's too much power in this number. It's freaking the whole response out': The views of key informants on evidence and targets to achieve hepatitis C elimination goals in Australia.', J Viral Hepat,

Journal articles | 2022

Bryant J; Horwitz R; Gray RM; Lafferty L; Jops P; Blunden H; Hudson S; Brener L, 2022, 'Improving access to drug and alcohol treatment in NSW Australia: The role of self-determination and peer support', Health and Social Care in the Community, 30, pp. e2050 - e2057,

Journal articles | 2022

Lafferty L; Cochrane A; Sheehan Y; Treloar C; Grebely J; Lloyd AR, 2022, '“That was quick, simple, and easy”: Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison', International Journal of Drug Policy, 99,

Journal articles | 2022

Lafferty L; Rance J; Byrne M; Milat A; Dore GJ; Grebely J; Lloyd AR; Treloar C, 2022, '“You need a designated officer” – Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting', International Journal of Drug Policy, 106,

Journal articles | 2022

Lafferty L, 2022, 'Navigating the dynamics of trust, rapport and power while conducting social health research with people in prison', Qualitative Social Work, 22, pp. 1222 - 1236,

Journal articles | 2022

Schroeder SE; Drysdale K; Lafferty L; Baldry E; Marshall AD; Higgs P; Dietze P; Stoove M; Treloar C, 2022, '"It's a revolving door": Ego-depletion among prisoners with injecting drug use histories as a barrier to post-release success', International Journal of Drug Policy, 101, pp. 103571,

Journal articles | 2022

Zhang Y; Guy R; Camara H; Applegate TL; Wiseman V; Treloar C; Lafferty L, 2022, 'Barriers and facilitators to HIV and syphilis rapid diagnostic testing in antenatal care settings in low-income and middle-income countries: A systematic review', BMJ Global Health, 7, pp. e009408,

Journal articles | 2021

Camara H; Zhang Y; Lafferty L; Vallely AJ; Guy R; Kelly-Hanku A, 2021, 'Self-collection for HPV-based cervical screening: a qualitative evidence meta-synthesis', BMC Public Health, 21, pp. 1503,

Journal articles | 2021

Grebely J; Collins AB; Artenie AA; Sutherland R; Meyer JP; Barocas JA; Falade-Nwulia O; Cepeda JA; Cunningham EB; Hajarizadeh B; Lafferty L; Lazarus JV; Bonn M; Marshall AD; Treloar C, 2021, 'Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs', International Journal of Drug Policy, 96,

Journal articles | 2021

Hill AO; Bavinton BR; Kaneko N; Lafferty L; Lyons A; Gilmour S; Armstrong G, 2021, 'Associations Between Social Capital and HIV Risk-Taking Behaviors Among Men Who Have Sex with Men in Japan', Archives of Sexual Behavior, 50, pp. 3103 - 3113,

Journal articles | 2021

Lafferty L; Rance J; Dore GJ; Grebely J; Lloyd AR; Treloar C, 2021, 'Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel', International Journal of Drug Policy, 98,

Journal articles | 2021

Lafferty L; Rance J; Dore GJ; Lloyd AR; Treloar C, 2021, 'The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting', Addiction, 116, pp. 1162 - 1171,

Journal articles | 2021

Lafferty L; Smith K; Causer L; Andrewartha K; Whiley D; Badman SG; Donovan B; Anderson L; Tangey A; Mak D; Maher L; Shephard M; Guy R; Bastian L; Ward J; Kaldor J; Comerford C; Bushby T; Moore L; Gunathilake M; Johnson D; Gallant D, 2021, 'Scaling up sexually transmissible infections point-of-care testing in remote Aboriginal and Torres Strait Islander communities: healthcare workers’ perceptions of the barriers and facilitators', Implementation Science Communications, 2, pp. 127,

Journal articles | 2021

Rance J; Lafferty L; Treloar C; Loveday S; Dore G; Lloyd A; Grebely J; Butler T; Martin N; Chambers G; Byrne M; Donnelly R; McGrath C; Bowman J; Trevethan L; Grant L; Murrell T; Bath N; Harrod M; Churchill A; Pinnock K; Cairnduff S, 2021, 'Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian ‘surveillance and treatment of prisoners with hepatitis C’ project (SToP-C)', Harm Reduction Journal, 18, pp. 46,

Journal articles | 2021

Rance J; Lafferty L; Treloar C; Loveday S; Dore G; Lloyd A; Grebely J; Butler T; Martin N; Chambers G; Byrne M; Donnelly R; McGrath C; Bowman J; Trevethan L; Grant L; Murrell T; Bath N; Harrod M; Churchill A; Pinnock K; Cairnduff S, 2021, 'Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the ‘Surveillance and Treatment of Prisoners with Hepatitis C’ project (SToP-C)', Addiction, 116, pp. 2761 - 2769,

Journal articles | 2021

Treloar C; Schroeder S; Lafferty L; Marshall A; Drysdale K; Higgs P; Baldry E; Stoove M; Dietze P, 2021, 'Structural competency in the post-prison period for people who inject drugs: A qualitative case study', International Journal of Drug Policy, 95, pp. 103261,

Journal articles | 2020

Camara H; Zhang Y; Lafferty L; Vallely A; Guy R; Kelly-Hanku A, 2020, 'Qualitative evidence synthesis on self-collection for human papillomavirus–based cervical screening: Protocol for systematic review', JMIR Research Protocols, 9,

Journal articles | 2020

Lafferty L; Rance J; Grebely J; Dore GJ; Lloyd AR; Treloar C, 2020, 'Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting', International Journal of Drug Policy, 77,

Journal articles | 2020

Rance J; Lafferty L; Treloar C, 2020, '‘Behind closed doors, no one sees, no one knows’: hepatitis C, stigma and treatment-as-prevention in prison', Critical Public Health, 30, pp. 130 - 140,

Journal articles | 2020

Sazzad HMS; McCredie L; Treloar C; Lloyd AR; Lafferty L, 2020, 'Violence and hepatitis C transmission in prison—A modified social ecological model', PLoS ONE, 15, pp. e0243106,

Journal articles | 2019

Lafferty L; Rance J; Treloar C, 2019, '‘Fighting a losing battle’: prisoners’ perspectives of treatment as prevention for hepatitis C with inadequate primary prevention measures', Drugs: Education, Prevention and Policy, 26, pp. 502 - 507,

Journal articles | 2019

Settumba SN; Shanahan M; Butler T; Schofield P; Lafferty L; Simpson P; Chambers G, 2019, 'Developing Attributes and Attribute-Levels for a Discrete-Choice Experiment: An Example for Interventions of Impulsive Violent Offenders.', Applied Health Economics and Health Policy,

Journal articles | 2018

Lafferty L; Chambers GM; Guthrie J; Butler T; Treloar C, 2018, 'Measuring Social Capital in the Prison Setting: Lessons Learned From the Inmate Social Capital Questionnaire', Journal of Correctional Health Care, 24, pp. 407 - 417,

Journal articles | 2018

Lafferty L; Rance J; Grebely J; Lloyd AR; Dore GJ; Treloar C, 2018, 'Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison', Journal of Viral Hepatitis, 25, pp. 1526 - 1532,

Journal articles | 2018

Lafferty L; Rance J; Treloar C, 2018, 'Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting', Drug and Alcohol Dependence, 183, pp. 96 - 101,

Journal articles | 2018

Lafferty L; Wild TC; Rance J; Treloar C, 2018, 'A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia's prisons', Harm Reduction Journal, 15, pp. 39,

Journal articles | 2018

hilferty F; Lafferty L; valentine K; Cale J; Zmudski F, 2018, 'Changes to home detention in South Australia: Evaluation design and early implementation findings', Advancing Corrections, 5th edition, pp. 34 - 47,

Journal articles | 2017

Lafferty L; Treloar C; Guthrie J; Chambers GM; Butler T, 2017, 'Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison', Journal of Viral Hepatitis, 24, pp. 111 - 116,

Journal articles | 2017

Lafferty L; Treloar C; van Breda N; Steele M; Hiley S; Flaherty I; Salmon A, 2017, '‘It's Fast, It's Quick, It Stops Me Being Sick’: How to influence preparation of opioid tablets for injection', Drug and Alcohol Review, 36, pp. 651 - 657,

Journal articles | 2016

Lafferty L; Treloar C; Butler T; Guthrie J; Chambers GM, 2016, 'Unlocking dimensions of social capital in the prison setting', Health and Justice, 4, pp. 9,

Journal articles | 2016

Lafferty L; Treloar C; Chambers GM; Butler T; Guthrie J, 2016, 'Contextualising the social capital of Australian Aboriginal and non-Aboriginal men in prison', Social Science and Medicine, 167, pp. 29 - 36,

Journal articles | 2015

Lafferty L; Chambers GM; Guthrie J; Butler T, 2015, 'Indicators of social capital in prison: a systematic review', Health & Justice, 3, pp. 3 - 7,
Reports | 2024

Broady T; Rance J; Cama E; Lafferty L; Brener L; Treloar C; Mao L; Holt M, 2024, Annual report of trends in behaviour 2024: Viral hepatitis, HIV, STIs and sexual health in Australia,

Reports | 2023

Broady T; Cama E; Rance J; Lafferty L; Brener L; Treloar C; Holt M; Mao L, 2023, Annual Report of Trends in Behaviour 2023: Viral Hepatitis, HIVSTIs and Sexual Health in Australia, Centre for Social Research in Health, UNSW Sydney., Sydney,

Conference Presentations | 2023

Lafferty L; Lewis S; Drysdale K; Monaghan R; Kelly-Hanku A; Guy R; Treloar C, 2023, 'Enablers and barriers to scaling up infectious diseases point-of-care testing in the primary care setting in Australia', presented at Australasian Conference on Point of Care Testing for Infectious Diseases, Sydney, 14 March 2023 - 15 March 2023

Other | 2023

Lafferty L; Thomas J; Gare J; Watts C; Marshall A, 2023, Speed geeking: how speed-dating techniques can tackle power imbalances at conferences, Nature,

Conference Abstracts | 2022

Carrington N; Patel P; Houghton R; Kenigsberg A; Slattery C; Purchas J; Prihaswan P; Browne M; Rautenbach C; Lafferty L; Murray C; Ryder N; McNulty A, 2022, 'MyCheck telehealth pilot: A new service modality supporting asymptomatic clients to navigate on-demand BBV/STI testing directly with commercial pathology providers.', in MyCheck telehealth pilot: A new service modality supporting asymptomatic clients to navigate on-demand BBV/STI testing directly with commercial pathology providers., presented at ASHM,

Conference Presentations | 2022

Lafferty L; Rautenbach C; McNulty A; Ryder N; Slattery C; Houghton R; Kenigsberg A; Murray C; Carrington N; Patel P, 2022, 'Client and staff perceptions of acceptability of an alternative telehealth testing pathway at Sydney Sexual Health Centre for bloodborne virus and sexually transmissible infections', presented at Joint Australasian HIV&AIDS and Sexual Health Conferences, Sunshine Coast, 29 August 2022 - 01 September 2022

Conference Presentations | 2022

Lafferty L; Schroeder S; Marshall A; Drysdale K; Higgs P; Stoove M; Baldry E; Dietze P; Treloar C, 2022, 'Trust and Service Engagement Among People Who Inject Drugs Post-Release', presented at International Conference on Health and Hepatitis in Substance Users (INHSU), Glasgow, Scotland, 19 October 2022 - 21 October 2022

Conference Presentations | 2022

Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd A; Treloar C, 2022, 'The role of point-of-care hepatitis C RNA testing at prison intake for reducing barriers to the hepatitis C care cascade', presented at Australasian Viral Hepatitis Conference, Brisbane, 29 May 2022 - 31 May 2022

Reports | 2022

Lafferty L; Whitford K; Whybrow B; Williams S; Nikitas A; Haire B, 2022, Girinyalanha Giilang (Talking about a Story): Enablers and barriers to sexual health resources among young Aboriginal and Torres Strait Islander people in Murrumbidgee Local Health District Community Report, The Kirby Institute, UNSW Sydney, Sydney, ,

Reports | 2022

Lafferty L; Whitford K; Whybrow B; Williams S; Nikitas A; Haire B, 2022, Girinyalanha Giilang (Talking about a Story): Enablers and barriers to sexual health resources among young Aboriginal people in Murrumbidgee Local Health District Summary Report, The Kirby Institute, UNSW Sydney, Sydney, ,

Reports | 2022

Lafferty L, 2022, Girinyalanha Giilang (Talking About A Story): A qualitative study exploring barriers and enablers to sexual health information and services among young Aboriginal people in Murrumbidgee

Conference Presentations | 2022

Patel P; Lafferty L, 2022, 'An evaluation of MyCheck: a digital STI/BBV e-testing platform', presented at ASHM, 29 August 2022 - 01 September 2023

Reports | 2022

Patel P; Rautenbach C; Lafferty L, 2022, An Evaluation of MyCheck (BBV/STI e-testing pathway), The Kirby Institute, UNSW Sydney and The NSW Ministry of Health, Sydney,

Conference Abstracts | 2022

Treloar C; Broady T; Drysdale K; Brener L; Schroeder SE; Lafferty L; Marshall AD; Dietze PM; Higgs P; Stoove M; Baldry E, 2022, 'Changing attitudes of the general public towards people with prison and injecting drug use histories: A research-informed, co-designed, arts-based intervention', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S136 - S137,

Reports | 2021

Bryant J; Murphy D; Rance J; Storer D; Lafferty L; Brener L; Seale H; Bolt R, 2021, Summary 1: COVID-19 vaccine acceptability among priority populations, UNSW Centre for Social Research in Health, Sydney,

Conference Presentations | 2021

Lafferty L; Rance J; Dore G; Lloyd A; Treloar C, 2021, 'Scaling Up Hepatitis C Treatment within the Prison Setting: The Role of Social Capital', presented at Academic and Health Policy Conference on Correctional Health (ACCJH), Virtual (USA), 08 April 2021 - 10 April 2021

Conference Presentations | 2021

Lafferty L; Rance J; Grebely J; Dore G; Lloyd A; Treloar C, 2021, 'Correctional Officers and Health Staff Perspectives Of Hepatitis C Treatment As Prevention Scale Up Within The Prison Setting', presented at International Conference on Health and Hepatitis in Substance Users (INHSU), Virtual (International), 13 October 2021 - 15 October 2021

Conference Presentations | 2021

Lafferty L; Rance J; Grebely J; Dore G; Lloyd A; Treloar C, 2021, 'Perceptions and concerns of hepatitis c reinfection in the prison setting', presented at Justice Health Conference, Public Health Association Australia, Virtual (Australia), 03 November 2021 - 04 November 2021

Other | 2021

Drysdale K (ed.), 2021, The Hard Cell: Living Life on the Outside. The Hard Cell: Living Life on the Outside. Story 1: Exhaustion Story 2: Reflections Story 3: Hate this, Centre for Social Research in Health, UNSW Sydney, Sydney, Australia,

Reports | 2020

Bryant J; Horwitz R; Gray R; Lafferty L; Jops P; Blunden H; Brener L, 2020, Barriers and enablers associated with access and equity in alcohol and other drug treatment in NSW, UNSW Centre for Social Research in Health, Sydney,

Reports | 2020

Newman CE; Persson A; valentine K; Hamilton M; Bryant J; Wallace J; Drysdale K; Smith AKJ; Gray R; Lafferty L; Botfield J; Rance J; Cui J, 2020, my health, our family: documenting stories of family life in the context of HIV, hepatitis B or hepatitis C (summary report), UNSW Centre for Social Research in Health, Sydney,

Reports | 2019

Bryant J; Gray R; Hull P; Horwitz R; Lafferty L; Mao L; Treloar C, 2019, Research Brief - Understanding barriers and facilitators to the take up of new direct-acting antiviral hepatitis C treatments: The Observe study, Centre for Social Research in Health, UNSW Sydney, Sydney,

Reports | 2019

Cale J; Zmudzki F; Hilferty F; Lafferty L; Whitten T; Doyle M; valentine K, 2019, Evaluation of Home Detention in South Australia: Final Report, Social Policy Research Centre, UNSW Sydney, Sydney, ,

Conference Presentations | 2019

Lafferty L; Bryant J; Mao L; Hull P; Gray R; Treloar C, 2019, 'Understanding barriers and facilitators to the take up of new DAA hepatitis C treatments', presented at HARP Forum - 2019: The Millennial Edition, Sydney, 16 October 2019 - 17 October 2019

Conference Presentations | 2019

Lafferty L; Rance J; Treloar C, 2019, 'Injecting culture following prison-wide hepatitis c treatment scale-up: negotiating risk after cure', presented at Australasian Viral Hepatitis Elimination Conference, Sydney, Australia, 05 August 2019 - 06 August 2019

Reports | 2018

Bryant J; Rance J; Lafferty L; Treloar C, 2018, Annual Report of Trends in Behaviour 2018: Viral Hepatitis in Australia, Centre for Social Research in Health, UNSW Sydney, Sydney,

Reports | 2018

Cale J; Hilferty F; Lafferty L; Zmudzki F; valentine K, 2018, Evaluation of SA Home Detention: research report 1 (baseline analysis), Social Policy Research Centre, UNSW Sydney, Sydney, SPRC Report 21/17,

Reports | 2018

Delaney MT; Hill T; Lafferty L; valentine K; Fotheringham M, 2018, Evaluation of the Wesley's Team Casework Model for SHS Services, Social Policy Research Centre, UNSW Sydney, Sydney, ,

Conference Presentations | 2018

Rance J; Lafferty L; Treloar C, 2018, 'Reinfection and retreatment: Attitudes among prisoner participants from the Australian SToP-C study', presented at 7th International Symposium on Hepatitis Care in Substance Users, Cascais, Portugal, 19 September 2018 - 21 September 2018

Conference Presentations | 2018

Rance J; Lafferty L; Treloar C, 2018, 'The Matter of Reinfection: Attitudes among Australian Prisoners from the SToP-C Study', presented at Australasian Viral Hepatitis Conference 2018, Adelaide, 13 August 2018 - 15 August 2018

Conference Abstracts | 2018

Salmon AM; Silins E; Belackova V; Jauncey M; Day CA; Lafferty L; Wood W, 2018, 'SYMPOSIUM: ABOVE AND BEYOND - AN EXPLORATION OF CARE BEYOND SUPERVISED INJECTIONS AT THE UNITING MEDICALLY SUPERVISED INJECTING CENTRE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S14 - S14,

Reports | 2017

Bryant J; Rance J; Lafferty L; Treloar C, 2017, Annual Report of Trends in Behaviour 2017: Viral Hepatitis in Australia, Centre for Social Research in Health, UNSW Sydney, Sydney,

Conference Abstracts | 2017

Lafferty L; Rance J; Treloar C, 2017, 'P31 Treatment as prevention in the prison setting: prisoners’ perspectives', in Journal of Virus Eradication, Elsevier BV, Vol. 3, pp. 22 - 23,

Conference Abstracts | 2017

Lafferty L; Wild C; Rance J; Treloar C, 2017, 'P30 Scaling up or holding back? Contemplating treatment as prevention in the prison setting within Australia's current policy frameworks', in Journal of Virus Eradication, Elsevier BV, Vol. 3, pp. 22 - 22,

Theses / Dissertations | 2017

Lafferty LM; Butler T, 2017, Relationships Matter: Social Capital Theory and Hepatitis C Treatment Uptake among Men in Prison, UNSW Sydney,

Conference Posters | 2017

Lafferty LM; Rance J; Treloar C, 2017, 'Does Australia’s policy landscape support HCV treatment as prevention in the prison setting in the new DAA era?', New Jersey, USA, presented at 6th International Symposium on Hepatitis Care in Substance Users (INHSU), New Jersey, USA, 06 September 2017 - 08 September 2017

Conference Presentations | 2017

Lafferty LM; Rance J; Treloar C, 2017, 'Prisoners' perspectives of treatment as prevention for hepatitis C in the prison setting', presented at HEP DART, Hawaii, USA, 03 December 2017 - 07 December 2017

Conference Posters | 2017

Lafferty LM; Rance J; Treloar C, 2017, 'Scaling up or holding back? Contemplating treatment as prevention in the prison setting within Australia’s current policy frameworks.', Cairns, Queensland, presented at Australasian Viral Hepatitis Elimination Conference, Cairns, Queensland, 10 August 2017 - 11 August 2017

Conference Presentations | 2017

Lafferty LM; Rance J; Treloar C, 2017, 'Treatment as Prevention in the Prison Setting: Prisoners' Perspectives', presented at 6th International Symposium on Hepatitis Care in Substance Users (INHSU), New Jersey, USA, 06 September 2017 - 08 September 2017

Conference Posters | 2017

Lafferty LM; Rance J; Treloar C, 2017, 'Treatment as prevention in the prison setting: Prisoners’ perspectives', presented at Australasian Viral Hepatitis Elimination Conference, 10 August 2017 - 11 August 2017

Conference Abstracts | 2017

Rance J; Lafferty L; Treloar C, 2017, 'P52 ‘Behind closed doors, no one sees, no one knows’: stigma and treatment as prevention in prison', in Journal of Virus Eradication, Elsevier BV, Vol. 3, pp. 30 - 30,

Conference Posters | 2017

Rance JA; Lafferty L; Treloar C, 2017, '“Behind closed doors, no one sees, no one knows”: Stigma and treatment as prevention in prison', Cairns, presented at Australasian Viral Hepatitis Elimination Conference, Cairns, 10 August 2017 - 11 August 2017

Reports | 2017

Simpson PL; Butler T; Dodson M; Levy M; Kaldor J; Allsop S; Gray D; Wilhelm K; Al-Yaman F; Doyle M; Lafferty L, 2017, The Indigenous Offender Health Research Capacity Building Group Community Report, Kirby Institute, University of New South Wales, National Centre for Indigenous Studies, Australian National University, Winnunga Nimmityjah Aboriginal Health Service, National Drug Research Institute, Curtin University of Technology, Sydney

Conference Presentations | 2016

Lafferty LM; Treloar C; Butler T, 2016, 'Building social capital to promote HCV treatment in prison', presented at National Hepatitis Health Promotion Conference, Melbourne, Australia, 19 May 2016 - 20 May 2016

Conference Presentations | 2016

Lafferty LM; Treloar C; Chambers GM; Butler T; Guthrie J, 2016, 'Exploring dimensions of social capital of men in prison living with hepatitis C', presented at Social Research Conference on HIV, Viral Hepatitis and Related Diseases, 31 March 2016 - 01 April 2016

Conference Presentations | 2016

Lafferty LM; Treloar C; Guthrie J; Chambers GM; Butler T, 2016, 'Relationships Matter: Social capital theory and the delivery of hepatitis C treatment in prison', presented at 10th Australasian Viral Hepatitis Conference, Gold Coast, Australia, 29 September 2016 - 01 October 2016

Conference Presentations | 2016

Lafferty LM; Treloar C; Guthrie J; Chambers GM; Butler T, 2016, 'Utilising social capital to promote HCV treatment in prison', presented at 5th International Symposium on Hepatitis Care in Substance Users (INHSU), Oslo, Norway, 07 September 2016 - 09 September 2016

Conference Presentations | 2016

Lafferty LM; Treloar C; Steele M; van Breda N; Hiley S; Salmon A, 2016, 'Preparing Prescription Opiates for Injection: Understanding Preferences and Practices', presented at Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Sydney, Australia, 30 October 2016 - 02 November 2016

Conference Presentations | 2015

Lafferty LM; Guthrie J; Chambers GM; Butler T, 2015, 'Social capital of men in prison living with hepatitis C', presented at 2nd National Complex Needs Conference, 17 November 2015 - 18 November 2015

Conference Posters | 2015

Lafferty LM; Treloar C; Chambers GM; Butler T; Guthrie J, 2015, 'Identifying the social capital of men in prison screening positive for HCV', Hawaii, USA, presented at HEP DART 2015, Hawaii, USA, 06 December 2015 - 10 December 2015

Conference Posters | 2015

Lafferty LM; Treloar C; Chambers GM; Butler T; Guthrie J, 2015, 'Identifying the social capital of men in prison screening positive for HCV', Sydney, Australia, presented at 4th International Symposium on Hepatitis Care in Substance Users, Sydney, Australia, 07 October 2015 - 09 October 2015

Conference Presentations | 2013

Lafferty LM; Guthrie J; Chambers GM; Butler T, 2013, 'Determining social capital indicators for accessing treatment and changes in QALYs post-treatment: HCV treatment among inmates in NSW', presented at National Indigenous Health Conference, Cairns, Australia, 25 November 2013 - 27 November 2013

Conference Presentations | 2013

Lafferty LM, 2013, 'Determining social capital indicators for accessing treatment and changes in QALYs post-treatment: HCV treatment among inmates in NSW', presented at National Indigenous Health Conference, Cairns, Australia, 25 November 2013 - 27 November 2013

Media | 2023

Lafferty L; Harrod M; Barrett L; Ritter A, 2023, We can reduce drug-related harm to those in prison - so why the inequity of health care?, ,

Media | 2023

Lafferty L; Treloar C; Drysdale K, 2023, ‘They weren’t there when I needed them’: we asked former prisoners what happens when support services fail,

��

Paul Bourke Award for Early Career Research,��Academy of the Social Sciences in Australia (2023)

51�Թ�app

Follow

Dr Lise Lafferty

Follow me